Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026)
Ani Pharmaceuticals (ANIP) reported FCF Margin of 22.02% for Q1 2026, up 479.0% on a YoY basis from 3.8% in Q1 2025, and up 29.84% sequentially from 16.96% in Q4 2025.
Ani Pharmaceuticals (ANIP) FCF Margin (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 17 years of FCF Margin data on file, last reported at 22.02% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin rose 479.0% year-over-year to 22.02%; the trailing twelve-month figure through Mar 2026 stood at 21.92% (up 999.0% YoY), and the FY2025 full-year result was 20.85%, up 1052.0% from the prior year.
- FCF Margin advanced to 22.02% in Q1 2026, from 16.96% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 33.92% in Q4 2023 to a low of 29.77% in Q1 2022.
- A 5-year average of 11.51% and a median of 15.55% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 20807 bps in 2022 and soared 4763 bps in 2023, its largest moves.
- Tracing ANIP's FCF Margin over 5 years: stood at 4.93% in 2022, then jumped by 788 bps to 33.92% in 2023, then plunged by 55 bps to 15.31% in 2024, then climbed by 11 bps to 16.96% in 2025, then rose by 30 bps to 22.02% in 2026.
- Business Quant data shows ANIP's FCF Margin at 22.02% in Q1 2026, 16.96% in Q4 2025, and 16.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 22.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.02% |
| Dec 31, 2025 | 16.96% |
| Sep 30, 2025 | 16.66% |
| Jun 30, 2025 | 33.28% |
| Mar 31, 2025 | 17.23% |
| Dec 31, 2024 | 15.31% |
| Sep 30, 2024 | 0.17% |
| Jun 30, 2024 | 12.33% |
| Mar 31, 2024 | 12.40% |
| Dec 31, 2023 | 33.92% |
| Sep 30, 2023 | 27.89% |
| Jun 30, 2023 | 15.55% |
| Mar 31, 2023 | 17.86% |
| Dec 31, 2022 | -4.93% |
| Sep 30, 2022 | 5.01% |
| Jun 30, 2022 | -16.26% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -20.20% |
| Sep 30, 2021 | -7.30% |
| Jun 30, 2021 | -1.42% |